JENKINS GEORGE M 4

What Happened George M. Jenkins, a director of Palvella Therapeutics, purchased 445 shares of PVLA on 2026-03-30 in an open-market transaction at $112.30 per share, for a total reported cost of $49,974. This was a straight purchase (transaction code P), not an option exercise or award.

Key Details

• Transaction date: 2026-03-30; Filing date: 2026-04-01 (filed within the normal SEC reporting window).
• Price and amount: 445 shares at $112.30 each; total ≈ $49,974.
• Transaction type: Open-market purchase (code P).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 references "Eagles Mere Air Museum Foundation" (listed in the filing).

Context This was a direct open-market buy — purchases by insiders are often noted by investors as a positive indicator because they increase the insider's stake, though they do not prove a specific motive. There were no option exercises, grants, or gifts reported in this transaction.